Update in Management of Carcinoma Prostate

From 09 Sep 2017 8:00 AM : Till 09 Sep 2017 5:00 PM
Contact details Mr. Abhishek Singhal, Co-ordinator, Kidney and Urology Institute, Medanta - The Medicity
919971698710 2nd Floor Auditorium, Medanta – The Medicity Get Venue Directions
Authors/ Speakers Dr. Narmada Prasad GuptaDr. Prasun Ghosh
Dr. Varun Mittal Dr. Rakesh Khera Dr. Rajiv Yadav Dr. Manav Suryavanshi
+ 4 More

In an endeavour to create awareness about the latest techniques and treatments available for prostate cancer, Medanta – The Medicity today organized a scientific program on “Update in Management of Carcinoma Prostate.” The theme was to highlight the changing focus towards curative intent for localized as well as advanced and metastatic disease. Over 125 Surgeons, Physicians, Urologists, Radiation and Medical Oncologists from India and abroad participated in the unique conference. The program has been organized to mark the beginning of World Prostate Disease Month (September) and was headed by Dr. N.P. Gupta, Chairman, Kidney and Urology Institute, Medanta- The Medicity.

September is observed as Prostate Cancer awareness month and camps are conducted worldwide to spread awareness. With increase in life expectancy, adoption of newer lifestyles and screening using prostate specific antigen (PSA), the incidence of prostate cancer is on the rise. As per records of cancer registries maintained in different towns in India, the newly diagnosed cases of cancer prostate are increasing by 1% every year. In Delhi NCR cancer registry, it has become the second most common cancer in men, next only to lung cancer. 

Fifty-one faculty doctors and 75 delegates actively participated in the Update, which focused on understanding the management of Prostate Cancer and improving patient care in a cost effective way. Various topics were discussed like the role of radical prostatectomy, role of chemo-hormonal therapy, and how to define CRPC amongst others. Owing to better understanding of the disease and advances in treatment modalities, focus is changing from palliation to curative intent for localized, locally advanced and metastatic disease. This is achieved by multimodality treatment including surgery, radiation, hormonal treatment, chemotherapy and molecular targeted therapy. 

Speaking on the occasion, Dr. N.P. Gupta said, “In India, Prostate Cancer is the second most common cancer in males. Lately we have been witnessing that younger population is also being diagnosed with this disease. The advancements that have been made in the past decade have given us a chance to understand and help the patients of carcinoma prostate in a much better way. The different types of scientific tools and diagnostic methods will help us to provide a better care for our patients. We hope that the initiative will help in educating the doctors and guide them in their practices, in order to perform a safe surgery along with wholesome management and minimum complications.”